Table 1.
mAb (n = 568) | Non-mAb (n = 1044) | P value | |
---|---|---|---|
Age (years), mean | 62.8 | 60.7 | 0.0119 |
Gender, n (%) | |||
Male | 224 (39) | 418 (40) | 0.8314 |
Female | 344 (61) | 626 (60) | |
Race, n (%) | |||
Asian | 0 (0) | 4 (0.4) | 0.3040 |
Black | 138 (24) | 441 (42) | <0.0001 |
Hispanic | 0 (0) | 9 (1) | 0.0313 |
Other | 19 (3) | 30 (3) | 0.6492 |
White | 404 (71) | 550 (53) | <0.0001 |
Unknown | 7 (1) | 10 (1) | 0.6161 |
Risk factors median | 2 | 2 | |
Age ≥65 years, n (%) | 281 (49) | 498 (48) | 0.4982 |
BMI ≥35 kg/m2, n (%) | 197 (35) | 383 (37) | 0.4471 |
CKD, n (%) | 36 (6) | 155 (15) | <0.0001 |
DM, n (%) | 188 (33) | 381 (36) | 0.1904 |
Immunosuppressive disease, n (%) | 65 (11) | 143 (14) | 0.2137 |
Immunosuppressive treatment, n (%) | 54 (10) | 94 (9) | 0.7866 |
Age ≥55 cardiovascular disease, n (%) | 158 (28) | 321 (31) | 0.2311 |
Age ≥55 hypertension, n (%) | 325 (57) | 557 (53) | 0.1427 |
Age ≥55 chronic lung disease, n (%) | 48 (8) | 126 (12) | 0.0287 |
Abbreviations: BMI, body mass index; CKD, chronic kidney disease; DM, diabetes mellitus; mAb, monoclonal antibody.
Bolded values indicate a statistically significant result.